vialauditThe Roundup
KOVERA LABS · CLIENT RECORD·SNAPSHOT 2026-08-02

Evolabs Research: 18 Kovera certificates.

The lab's record shows 18 certificates printed for Evolabs Research, analysed between 31 Mar 2026 and 29 May 2026, covering 10 products. Median HPLC purity is 99.94%. Kovera graded 18 as a pass and 0 as a fail.

18
certificates
99.94%
median purity
10
products
0
lab verdict: fail
0
failure rules met

What the record shows

RETRIEVED 2 AUGUST 2026

None of the 18 certificates meets our failure rules: no lab fail, no unconfirmed identity, no purity under 95% and no content under 90% of the label. 12 measured more than 110% of the label, which Kovera does not grade as a fail.

Kovera revised 7 of these certificates after first publication, under the same report number: KVR-2026-EE331E (revised by the lab 2026-05-30: purity 99.788% → 99.731%, content 9.68 → 10.76 mg); KVR-2026-DF4A78 (revised by the lab 2026-05-30: purity 99.564% → 99.537%, content 52.25 → 53.81 mg); KVR-2026-AEC9DB (revised by the lab 2026-05-30: purity 98.552% → 99.528%, content 11.06 → 11.33 mg); KVR-2026-9F405D (revised by the lab 2026-05-30: purity 99.364% → 99.771%, content 5.19 → 5.67 mg); KVR-2026-129E57 (revised by the lab 2026-05-30: purity 99.629% → 99.402%, content 508.65 → 543.18 mg); KVR-2026-019FBF (revised by the lab 2026-05-30: purity 99.511% → 99.671%, content 11.38 → 5.59 mg); KVR-2026-83D3C6 (revised by the lab 2026-06-10: purity 98.977% → 98.98%, content 11.59 → — mg). Why that matters is in our revisions analysis.

A certificate covers the sample the client sent, and the client decides which results go public. The figures are as published on 2 August 2026; check the lab's verify page for the current version before you rely on one.

Products tested

10 AS PRINTED
Retatrutide · 4Semaglutide · 4Tirzepatide · 3BPC-157 · 1GHK-Cu · 1MOTS-c · 1NAD+ · 1PT-141 · 1Semax · 1Tesamorelin · 1

Every certificate

NEWEST FIRST · 18 ROWS
ReportProductLotPurity% of labelAnalysedResultCheck
KVR-2026-EE331ETesamorelinEVO521202699.731%107.6%10.76 of 10 mg29 May 2026PASSrevised by the lab 2026-05-30: purity 99.788% → 99.731%, content 9.68 → 10.76 mgKovera ↗our verifier →
KVR-2026-DF4A78GHK-CuEVO521202699.537%107.6%53.81 of 50 mg29 May 2026PASSrevised by the lab 2026-05-30: purity 99.564% → 99.537%, content 52.25 → 53.81 mgKovera ↗our verifier →
KVR-2026-AEC9DBPT-141EVO521202699.528%113.3%11.33 of 10 mg29 May 2026PASSover 110% of labelrevised by the lab 2026-05-30: purity 98.552% → 99.528%, content 11.06 → 11.33 mgKovera ↗our verifier →
KVR-2026-9F405DBPC-157EVO521202699.771%113.4%5.67 of 5 mg29 May 2026PASSover 110% of labelrevised by the lab 2026-05-30: purity 99.364% → 99.771%, content 5.19 → 5.67 mgKovera ↗our verifier →
KVR-2026-129E57NAD+EVO521202699.402%108.6%543.18 of 500 mg29 May 2026PASSrevised by the lab 2026-05-30: purity 99.629% → 99.402%, content 508.65 → 543.18 mgKovera ↗our verifier →
KVR-2026-019FBFSemaxEVO521202699.671%111.8%5.59 of 5 mg29 May 2026PASSover 110% of labelrevised by the lab 2026-05-30: purity 99.511% → 99.671%, content 11.38 → 5.59 mgKovera ↗our verifier →
KVR-2026-83D3C6MOTS-cEVO521202698.98%116.3%11.63 of 10 mg23 May 2026PASSover 110% of labelrevised by the lab 2026-06-10: purity 98.977% → 98.98%, content 11.59 → — mgKovera ↗our verifier →
KVR-2026-FC7E39Tirzepatide0404202699.932%117.6%23.52 of 20 mg31 Mar 2026PASSover 110% of labelKovera ↗our verifier →
KVR-2026-E78C2ESemaglutide0404202699.962%106.1%10.61 of 10 mg31 Mar 2026PASSKovera ↗our verifier →
KVR-2026-D98793Semaglutide0404202699.984%109.6%32.89 of 30 mg31 Mar 2026PASSKovera ↗our verifier →
KVR-2026-CE4F8DSemaglutide0404202699.972%116.6%5.83 of 5 mg31 Mar 2026PASSover 110% of labelKovera ↗our verifier →
KVR-2026-BB05ACRetatrutide0404202699.938%111.4%5.57 of 5 mg31 Mar 2026PASSover 110% of labelKovera ↗our verifier →
KVR-2026-987423Retatrutide0404202699.943%115.8%23.16 of 20 mg31 Mar 2026PASSover 110% of labelKovera ↗our verifier →
KVR-2026-9518F7Tirzepatide0404202699.988%110.8%5.54 of 5 mg31 Mar 2026PASSover 110% of labelKovera ↗our verifier →
KVR-2026-8EB1C8Tirzepatide0404202699.981%118.2%11.82 of 10 mg31 Mar 2026PASSover 110% of labelKovera ↗our verifier →
KVR-2026-7F44C0Retatrutide0404202699.957%115.1%34.54 of 30 mg31 Mar 2026PASSover 110% of labelKovera ↗our verifier →
KVR-2026-44488BSemaglutide0404202699.923%109.8%21.97 of 20 mg31 Mar 2026PASSKovera ↗our verifier →
KVR-2026-28B13ARetatrutide0404202699.969%118.2%11.82 of 10 mg31 Mar 2026PASSover 110% of labelKovera ↗our verifier →

More from the index

ALL KOVERA CLIENTS →
THE ROUNDUP · MONTHLY

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 SUBSCRIBERS·0 SPONSORED ITEMS·11 ISSUES SINCE LAUNCH